GlassScriptPhysician profile
Wen Chen
NPI 1992123764
$6,127.58
in general payments reported to CMS, 2019-2025
42 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $1,080 · 2021: $793 · 2022: $1,017 · 2023: $910 · 2024: $588 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.96 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,203.31 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Alexion Pharmaceuticals, INC. | $554.27 | 2019-2024 | Ultomiris |
| Genentech USA, INC. | $461.59 | 2019-2024 | Ocrevus, Ocrevus Zunovo |
| Ucb, INC. | $307.91 | 2019-2025 | Rystiggo, Briviact |
| Amgen INC. | $303.27 | 2019-2023 | Aimovig |
| Abbvie INC. | $259.30 | 2019-2025 | Botox, Duopa, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $190.35 | 2019-2022 | |
| Genzyme Corporation | $145.28 | 2019-2023 | |
| Pfizer INC. | $127.81 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.44 | 2022 | |
| Amneal Pharmaceuticals LLC | $116.57 | 2019-2024 | Ongentys |
| Sk Life Science, INC. | $114.72 | 2020-2023 | |
| Allergan, INC. | $112.71 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $95.76 | 2021-2025 | Ajovy, Austedo Xr |
| Mallinckrodt Hospital Products INC. | $94.99 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.